Exam 3 Flashcards

1
Q

What does ADME stand for?

A

Absorption, Distribution, Metabolism, and Excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the three primary means to quantify drug effect?

A

Onset, duration and intensity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What goes on 1, 2, and 3?

A

1: Intensity
2: Duration
3. Onset

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What happens onset, intensity and duration on the red line in comparison to the black?

A

Onset: same, intensity: decreases, duration: increases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Two reasons why less than 100% of a dose may reach the site of action

A

Degradation and excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

The study of the absorption, distribution, biotransformation, and elimination of xenobiotics

A

pharmacokinetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

The study of the molecular, biochemical, and physiological effects of xenobiotics and their mechanisms of actions

A

pharmacodynamics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

The fate of a drug after it has entered the systemic circulation

A

drug disposition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What three aspects make up pharmacotherapeutics?

A

pathophysiology, pharmacodynamics, and pharmacokinetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What was the greatest reason why drugs failed in Phase I of clinical trials in 1991? What was the %? What changed to lower the percentage (and what’s the %s value)?

A

Biggest reason: pharmacokinetics/bioavailability (40%)
Development of improved preclinical ADME greatly reduced drug attrition due to poor PK/bioavailability (<10%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What route of administration has the most rapid onset? Slowest?

A

Fastest: IV slowest: smoked

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the four routes of administration?

A

ingestion, inhalation, dermal, and parenteral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

A reduction in the extent of absorption will impact which of the three measures of pharmacologic effect: onset, intensity, and/or duration?

A

Intensity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

A reduction in the speed of entry into the systemic circulation will impact which of the three measures of pharmacologic effect: onset, intensity, and/or duration?

A

Onset

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Barriers and blood flow can impact both the speed and extent of ________ of a drug in the body

A

distribution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Of the four consequences of metabolism, what process is used for active to inactive metabolites?

A

phenobarbital -hydroxylation-> Hydroxyphenobarbital

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Of the four consequences of metabolism, what process is used for active to active metabolites

A

Procainamide -acetylation-> N-acetylprocainamide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Of the four consequences of metabolism, what process is used for inactive to active metabolites

A

Codeine -demethylation-> morphine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Of the four consequences of metabolism, what process is used for active to reactive metabolites

A

Acetaminophen -> reactive metabolite

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

A ______ in the extent of absorption will reduce the peak drug conc. and the time the drug conc. remains above the minimally effective conc.

A

reduction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

A reduction in the speed of entry into the systemic circulation will (inc/dec) the time it takes for the drug conc. to reach the minimally effective conc. Which part of the curve will be most impacted?

A

increase; the onset

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What barrier can significantly reduce the amount of drug that enters the site of action?

A

tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

The graph below shows the conc vs time curve for two formulations of a bupropion. Compared to “Budeprion XL” (green), the maximal intensity of the pharmacologic effect for “Wellbutrin XL (red)” would be expected to occur:
a. later
b. sooner
c. at the same time

A

a. later

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What percent of drug currently fail in clinical trials due to problems with the ADME of the compounds?
A. ~40%
B. <10%
C. 25%

A

B. <10%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Which route of admin. would be expected to produce the most rapid onset of pharmacologic effect? a. oral b. dermal c. subcutaneous d. intravenous e. intramuscular
d. intravenous
26
Morphine is a metabolite of codeine and this metabolite is responsible for the analgesic effect when codeine is admind. In a patent who has a genetic defect such that they cannot metabolize codeine, the magnitude of pain relief would be expected to be (incr/decr/same) compared to normal pateints?
decreased
27
Which route of admin. avoids the need to cross a biological membrane in order to reach the systemic circulation?
intravenous
28
Which route of admin. avoids the need to cross a biological membrane in order to reach the CNS?
None
29
What impact would a drug that speeds up stomach emptying (metoclopramide) have on the time to peak conc for acetaminophen?
The peak drug conc would be higher
30
In Fick's equation, if the diffusion rate increases, what happens to the concentration?
Increases directly
31
For a drug which undergoes passive diffusion, the rate of transport across the membrane should (incr/decr/same) as the concentration increases
increase
32
What site in the GI tract is where most drug absorption occurs? Why?
Small intestine: covered in folds of Kercking with villi containing microvilli. This increases the surface area and transit time (~3-5hrs)
33
The passive movement of drug through lipid membranes
transcellular diffusion
34
The passive movement of drugs between cells via tight junctions.
paracellular diffusion
35
A carrier-mediated process that involves a transport protein which moves drug with a conc. gradient
facilitated diffusion
36
A carrier-mediated process that requires energy.
active transport
37
What types of transport are passive? Carrier-mediated?
Passive: transcellular and paracellular Carrier-mediated: facilitated and active
38
Which transports are driven or move with a concentration gradient? A. Transcellular B. Facilitated C. Paracellular D. Active Transport
trans and para driven and facilitated moved
39
In a base solution, which pKa(><=)pH is favorable? Acid?
Base: pKapH favorable
40
T or F: Gastrointestinal transit time does NOT influence the extent and rate of drug absorption
False
41
What type of diffusion in saturable and subject to competitive drug-drug interactions?
passive
42
Transporter that removes solute (drug) out of the cell, reducing the amount of drug that accumulates in certain tissues, such as the brain
Efflux transporters
43
Slowing gastric emptying would be expected to have what effect on the absorption of a drug absorbed by passive diffusion? a. it will take longer to achieve the peak conc. b. the peak conc. will occur sooner c. slowing gastric emptying will have no effect on the timing of the peak conc. of the drug
a. it will take longer to achieve the peak conc.
44
Which of the following mechanisms moves drug down a conc gradient? a. Paracellular diffusion b. Transcellular diffusion c. Facilitated diffusion d. active transport e a&b f a, b, & c g. All of the above
f. a, b, and c
45
Co-admin of an inhibitor of the efflux protein p-glycoprotein (pgp) would be expected to have what effect on the oral absorption of a drug that is a substrate for pgp? a. the inhibitor of pgp will increase the amt of drug absorbed b. the inhibitor of pgp will decrease the amt of drug absorbed c. the inhibitor of pgp will not change the amt of drug absorbed
a. the inhibitor of pgp will increase the amt of drug absorbed
46
Which of the following modifications would be not expected to increase the transcellular permeability of a drug molecule? a. Removing ionized groups b. Decreasing lipophilicity c. Reducing molecular size
b. Decreasing lipophilicity
47
What type of cell movement is frequently used for nanoparticle drug delivery?
endocytosis
48
A process by which a cell engulfs and internalizes a particle
endocytosis
49
Describe the effect of drug distribution on the concentration vs time curve: When is the highest dose achieved? Profusion?
Highest dose is achieved right after drug is administered. Highly profuse tissue will distribute drug more rapidly.
50
Differentiate between perfusion rate limited and permeability rate limited distribution of drug into tissues
Perfusion rate limited: little membrane barrier causing more rapid movement of molecules from blood to body tissues Permeability rate limited: greater membrane barrier causing lower movement of molecules from blood to body tissues
51
The movement of drug molecules across vascular endothelial cells and into tissue interstitial space
transvascular transport
52
A transvascular transport process that is driven by pressure
convection
53
A transvascular trasnport process that is driven by a concentration gradient
diffusion
54
Will perfusion rate limited or permeability rate limited show slower tissue distribution?
Permeability
55
What method of transvascular transport is likely to be important for monoclonal antibodies?
Convection
56
Describe how differences in tissue pH may result in the trapping of ionizable drugs
When going from a higher pH to lower pH, the drug may be uncharged in the higher pH allowing it to be transported through the membrane then become charged in the lower pH, "trapping" it from crossing the membrane and allowing excretion
57
Describe how plasma protein binding effects distribution and pharmacologic effect
Drugs bound to plasma proteins limit distribution in tissues since only free drug can cross endothelial membrane
58
4 ways drug may gain access to the CNS
(Appropriate DDT) *appropriate physiochemical properties *Disruption of the blood brain barrier *Direct admin into CNS (most common: spinal tap) *Utilize an existing transporter
59
How to choose the best meds for a pregnant woman
Free drug will pass through fetal liver, so we want a large molecule
60
The conc of drug within a tissue due to pH difference that lead to ionization of the drug in the tissue environment
drug trapping
61
The initial movement of drug from highly perfused tissues to poorly perfused tissues
redistribution
62
What organ is called a "privileged site"? why?
Brain- it excludes many compounds from entering the CNS
63
What efflux transporter is used in the CNS to prevent drugs from accumulating in the brain?
p-glycoprotein (pgp or MDR1)
64
(Polar/Non-Polar) drugs do NOT usually cross the placenta
Polar- its the best choice for prego women
65
T or F: A drug that is only distributed into vascular space will exhibit a monoexponential blood conc vs time curve after intravenous admin.
True
66
Which of the following drugs is most likely to undergo transvascular transport via convection? a. asprin (MW 180 g/mole) b. cimetidine (MW 252 g/mole) c. Vancomycin (MW 143 g/mole) d. Idarucizumab (MW 48k Daltons) e. a, b, c f. none of the above
d. Idarucizumab (MW 48k Daltons)
67
A decrease in the plasma protein binding of a drug would be expected to have what effect on the distribution of drug into tissue? A. a decrease in protein binding will increase the amount of drug in tissue B. A. a decrease in protein binding will decrease the amount of drug in tissue A. a decrease in protein binding will not change the amount of drug in tissue
A. a decrease in protein binding will increase the amount of drug in tissue
68
A change in the structure of a drug molecule such that it is no longer transported by pgp (MDR1) would be expected to have what effect on the CNS conc. of drug compared to the original drug? A The new drug would have a lower conc. in the CNS B The new drug would have a higher conc. in the CNS C. A The new drug would have the same conc. in the CNS
B The new drug would have a higher conc. in the CNS
69
The primary route drugs are excreted from the body
renal (kidney) and hepatic
70
Identify the key process and anatomical location involved in renal excretion
Filtration: beginning (afferent) Secretion: Proximal convoluted tubule (PCT) Absorption: Loop of Henle Biotransformation
71
What is the relationship in glomerular filtration?
72
What is the molecular size limit for glomerular filtration?
MW<5000
73
Creatinine vs clearance relationship for a drug eliminated by filtration
74
Elimination of which of the following drug molecular weight would be unaffected by renal disease? A. ~15,000 B. 500 C. 10
A. 15,000
75
Drugs that undergo ATC are... A. susceptible to competitive interaction B. exhibit stereoselective renal excretion C. Unsaturable D. Only A and B E. All of the above
D. (C should be saturable)
76
The active transport of drug from blood into the renal tubule, occurring primarily in the proximal tubule
Active tubular secretion (ATS)
77
The movement of solute from inside the renal tubule back into the blood. Passive and driven by high conc. that occurs as a result of the large fraction of filtrate that is reabsorbed.
Tubular reabsorption
78
The reabsorption of drug from the small intestine after drug has been excreted through the bile into the intestine
enterohepatic recirculation
79
The process by which food stimulates release of bile, and drug contained therein, into the small intestine, followed by reabsorption of the drug.
dose dumping
80
What is glomerular filtration largely influenced by?
Molecular size and plasma protein binding
81
T of F: Most tubular reabsorption is driven by carrier-mediated diffusion
F: concentration gradient (passive)
82
When (this type of reabsorption) occurs, the process is saturable.
carrier-mediated tubular reabsorption
83
What are the two processes of hepatic elimination?
metabolism (biotransformation) and biliary excretion
84
First or second pass effect: Blood draining the stomach and small intestine flowing into the portal vein, all absorbed drug passing through the liver before entering the rest of the body
First
85
T or F: pgp secretes drug from the hepatocyte into bile
T
86
What are the primary factors determining biliary secretion?
Molecular weight and polarity
87
(Small/Large) polar molecules are mostly eliminated in the bile
Large
88
Which of the following renal excretory processes for drugs is most likely subject to competitive drug-drug interactions? a. filtration b. tubular secretion c. tubular reabsorption d. b and c e all of the above
b
89
In examining the renal elimination of a series of chemically related compounds, as molecular weight increases the extent of filtration will (increase/decrease/not have an influence)
decrease
90
If enterohepatic recirculation (EHR) increases, the half-life of a drug will (Increase/decrease/no effect)
increase
91
For a drug that is eliminated solely by glomerular filtration, a decrease in plasma protein binding will result in an (incr/decr) in the renal elimination of the drug
increase
92
Which of the following vitamins undergo bioactivation in the kidney? a. Vit A b. Vit B c. Vit C d. Vit D e. Vit E
d. Vit D
93
Half-life (t 1/2) is influenced by _______
metabolism
94
What is the first organ exposed to compounds absorbed in the gut?
Liver
95
Which phase (I or II) using chemical modification (biotransformation) including oxidation, hydroxylation, etc. to introduce new functional group or expose group
Phase I
96
Which phase (I or II) conjugated the polar group with drug
Phase II
97
Phase I reactions typically occur by (oxidation/reduction) and are catalyzed by (cypP450/NADPH/O2) utilizing (cypP450/NADPH/O2) and (cypP450/NADPH/O2)
Phase I reactions typically occur by oxidation and are catalyzed by cypP450 utilizing NADPH and O2
98
CYP2D6*1A Identify the allele, subfamily, family and individual gene
CYP2(Family)D(subfamily)6(individual gene)*1A(allele)
99
The active site of CYP contains an ____-_____ cofactor
iron-heme
100
Factors that determine binding strength in reversible inhibition
coordination, hydrophobic, and specific contacts